Table 1.
Clinical characteristics of the study cohort
| Patient | Age at Diagnosis, y | Sex | MGMT | IDH1 | Regions Sampled, n | Max. Tumor Diameter, cm | Tumor Volume, cm3 | Cellularity (S1/S2/S3/S4) | Necrosis (S1/S2/S3/S4) |
|---|---|---|---|---|---|---|---|---|---|
| B42 | 70.1 | F | 1 | WT | 2 | 5.3 | 13.5 | 75/75 | 10/10 |
| B58 | 66.4 | M | 0 | WT | 2 | 5.5 | 29.3 | 85/70 | 20/5 |
| B65 | 54 | F | 0 | WT | 2 | 5.6 | 26.5 | 60/80 | 5/0 |
| B67 | 60.4 | F | 0 | WT | 2 | 7.2 | 48.0 | 40/60 | 50/50 |
| B71 | 60.4 | M | 0 | WT | 2 | 4 | 13.2 | 65/70 | 50/70 |
| B72 | 76.6 | M | 1 | WT | 2 | 5.4 | 21.1 | 80/65 | 5/15 |
| B74 | 62.6 | F | 1 | WT | 2 | 5.2 | 23.5 | 70/70 | 10/70 |
| W016 | 56 | F | WT | 2 | 5.2 | 14.1 | 60/40 | 10/0 | |
| W059 | 71 | F | 1 | WT | 2 | 5 | 14.9 | 90/85 | 5/20 |
| B103 | 74.3 | M | 1 | WT | 4 | 5.5 | 27.5 | 70/45/70/70 | 50/5/10/5 |
Note. MGMT: 0 = methylated; 1 = unmethylated. IDH1 by R132H immunohistochemistry and exome sequencing.